Cargando…

Orphan drugs expenditure in the Netherlands in the period 2006–2012

BACKGROUND: The relatively low budget impact of orphan drugs is often used as an argument in reimbursement decisions. However, overall, the budget impact of orphan drugs can still be substantial. In this study, we assess the uptake and budget impact of orphan drugs in the Netherlands. METHODS: We ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanters, Tim A, Steenhoek, Adri, Hakkaart, Leona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195995/ https://www.ncbi.nlm.nih.gov/pubmed/25304026 http://dx.doi.org/10.1186/s13023-014-0154-0

Ejemplares similares

Systematic review of available evidence on 11 high-priced inpatient orphan drugs
por: Kanters, Tim A, et al.
Publicado: (2013)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
por: van den Brink, Rinke
Publicado: (2014)

Determinants of drug expenditure in the Swiss healthcare market in 2006
por: Eggli, Yves, et al.
Publicado: (2022)

An analysis of orphan medicine expenditure in Europe: is it sustainable?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2019)

Imported Dengue Fever in Tuscany, Italy, in the Period 2006 to 2012
por: Lagi, Filippo, et al.
Publicado: (2014)

Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
por: Herder, Matthew, et al.
Publicado: (2016)

Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study
por: Mulders-Manders, Catharina M., et al.
Publicado: (2018)

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
por: Al, Maiwenn J, et al.
Publicado: (2010)

Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
por: Pijeira Perez, Yankier, et al.
Publicado: (2023)

Increasing sexually transmitted infection rates in young men having sex with men in the Netherlands, 2006–2012
por: Koedijk, Femke DH, et al.
Publicado: (2014)

In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era
por: Brouwer, Werner, et al.
Publicado: (2021)

Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
por: Usher, Cara, et al.
Publicado: (2019)

Update of the Dutch manual for costing studies in health care
por: Kanters, Tim A., et al.
Publicado: (2017)

Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs
por: de Vries, Eline F., et al.
Publicado: (2021)

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
por: Kanters, Tim A, et al.
Publicado: (2014)

Socioeconomic differences in healthcare expenditure and utilization in The Netherlands
por: Loef, Bette, et al.
Publicado: (2021)

Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic
por: Huls, Samare P. I., et al.
Publicado: (2021)

2006 Budget - Transfers and Expenditure in Excess of Provisions
Publicado: (2006)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

Estimating the clinical cost of drug development for orphan versus non-orphan drugs
por: Jayasundara, Kavisha, et al.
Publicado: (2019)

Costs of Persons with Dementia Living in Nursing Homes in The Netherlands
por: Klein, Philip Charles Gerard, et al.
Publicado: (2022)

Screening of cervical cancer in Catalonia 2006–2012
por: de Sanjosé, Silvia, et al.
Publicado: (2015)

Travel-related Dengue Virus Infection, the Netherlands, 2006–2007
por: Baaten, Gijs G.G., et al.
Publicado: (2011)

Productivity and quality of Dutch hospitals during system reform
por: van Ineveld, Martin, et al.
Publicado: (2015)

Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands
por: van der Kolk, Annemarie, et al.
Publicado: (2015)

Compassionate use of orphan drugs
por: Hyry, Hanna I., et al.
Publicado: (2015)

A conceptual disease model for adult Pompe disease
por: Kanters, Tim A., et al.
Publicado: (2015)

Confidential enquiry into maternal deaths in the Netherlands, 2006–2018
por: Kallianidis, Athanasios F., et al.
Publicado: (2022)

Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012
por: Yin, Qing-Qin, et al.
Publicado: (2016)

Surveillance and characteristics of food-borne outbreaks in the Netherlands, 2006 to 2019
por: Friesema, Ingrid HM, et al.
Publicado: (2022)

Changing profile of rotavirus genotypes in Bangladesh, 2006–2012
por: Afrad, Mokibul Hassan, et al.
Publicado: (2013)

Changes in the Prevalence of Diabetes Mellitus in Bulgaria (2006–2012)
por: Borissova, Anna-Maria, et al.
Publicado: (2015)

Manned spaceflight log II—2006–2012
por: Shayler, David J, et al.
Publicado: (2013)

Young male sex workers are at high risk for sexually transmitted infections, a cross-sectional study from Dutch STI clinics, the Netherlands, 2006–2012
por: Fournet, N., et al.
Publicado: (2016)

Impact of orphan drugs on Latvian budget
por: Logviss, Konstantins, et al.
Publicado: (2016)

Patient access to orphan drugs in France
por: Bourdoncle, Marion, et al.
Publicado: (2019)

Burden of illness of Pompe disease in patients only receiving supportive care
por: Kanters, Tim A., et al.
Publicado: (2011)

Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010)

Orphan drugs: Indian perspective
por: Kumar, Harish, et al.
Publicado: (2017)

Changes in admission to long-term care institutions in the Netherlands: comparing two cohorts over the period 1996–1999 and 2006–2009
por: Alders, Peter, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cpc0lrh53ltm9git0dalsu0037